Watch the webinar here. CEO Leanne Wells and Policy Manager Jo Root discuss the CHF analysis of the 2018 Health Budget and its implications for consumers.
Read the full position here. We support Aboriginal and Torres Strait Islander peoples’ right to be listened to in the Australian Parliament and acknowledged in the Australian Constitution
The Consumers Health Forum believes all...
Overall CHF supports the recommended priorities and actions and welcomes the commitment to further consultation with children, families and young people as implementation plans are developed and operationalised. We welcome ARACY’s proposed life course approach: it is important that the plan...
We are pleased to provide a submission supporting the continuation and strengthening of the Tobacco Control Regulations in Australia. Since the...
Response to the Report from the General Practice and Primary Care Clinical Committee: Phase 2
CHF supports the changes that the GPPCCC have been made in their Phase 2 Report and feel that their vision of the health system aligns closely with what we hear from members. We are pleased that...
CHF appreciates the opportunity to provide a comment to the Therapeutic Goods Administration (TGA) proposal to introduce a Unique Device Identification (UDI) system for medical devices in Australia.
At the heart of CHF’s policy agenda is patient-centred care. Our responses to the TGA’s...
Consumers Health Forum of Australia (CHF) appreciates the opportunity to provide feedback in response to the proposed Standard for Informed Financial Consent (the Standard), developed by the Cancer Council, Breast Cancer Network Australia, CanTeen and Prostate Cancer Foundation.
CHF...
The CHF supports the reintroduction of pills into the scope of the remade Order. The omission of these from the current Order is an unfortunate regulatory oversight. Consumers implicitly trust the regulatory system to ensure any product made available to them undergoes rigorous assessment of...